Health Care in Focus as President Trump Addresses the Nation
In his State of the Union address, President Trump described the need to rein in health care costs as a “major priority for me.” And for the president, this includes the need to lower the cost of prescription drugs for American patients – an urgent priority also shared by those within the biotechnology industry. As BIO’s President and CEO, Jim Greenwood, said on Tuesday:
“[Our] industry is eager to help deliver responsible solutions that ensure prescription drugs ar
Read more »